Stay updated on Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov site revision label changes from v3.8.0 to v3.8.1; the study record content appears unchanged.SummaryDifference0.0%

- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the completed SUNNIFORECAST study is displayed with its trial design, eligibility criteria, study locations, outcome measures, investigators, and related publications.SummaryDifference67%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check32 days agoChange DetectedA site-wide NIH notice about terminology changes was added above the ClinicalTrials.gov page, and the site revision changed from v3.7.1 to v3.7.2. The page content still displays a 403 Forbidden error.SummaryDifference1%

- Check46 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error with a simple header and Home link, replacing the previous study record details and related navigation.SummaryDifference19%

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.